ReviewACS omega2026
Overview of Optical Fiber Biosensors for the Detection of Cancer Biomarkers in the Past Decade.
Review in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Early-stage detection of cancer plays a pivotal role in reducing mortality and improving patient survival. Consequently, extensive research has been directed toward the development of innovative diagnostic platforms that exploit cancer-specific biomarkers. These biomarkers encompass a diverse array of biological molecules including nucleic acids, proteins, enzymes, hormones, cytokeratins, and cell surface receptors that provide valuable insights into disease onset, progression, and therapeutic response. This review provides a comprehensive overview of recent progress in the design and application of optical fiber biosensors (OFBs) for the detection of cancer biomarkers. It systematically summarizes key cancer types and associated biomarkers, their physiological and pathological concentration ranges, and the corresponding sensing mechanisms utilized for their quantification. Emphasis is placed on the fundamental configurations of optical fiber biosensing systems, along with their working principles. Emerging trends and future research directions are also outlined to accelerate the development of next-generation OFBs for real-time and point-of-care cancer diagnostics.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.